COVID-19
Indiana life sciences leaders are tackling COVID-19 through drug development, lab testing, research and data. Indiana Life Sciences Innovators Working to Combat COVID-19
COVID-19
Indiana life sciences leaders are tackling COVID-19 through drug development, lab testing, research and data. Indiana Life Sciences Innovators Working to Combat COVID-19
BioCrossroads is a Catalyst IN the life sciences. Our mission is to serve as a stimulus for the continued growth of Indiana’s robust life sciences industry.
BioCrossroads is a Catalyst IN the life sciences. Our mission is to serve as a stimulus for the continued growth of Indiana’s robust life sciences industry.
ENGAGE IN
Emergency Use Authorizations – vaccines, therapies, diagnostics and policy
Gain a more practical understanding of emergency use authorizations, learn about how mRNA vaccines differ from others, and discuss the efficacy and safety of EUA diagnostics, therapies and vaccines
WE ARE IN
LIFE SCIENCES
BioCrossroads is a catalyst for Indiana’s diverse and robust life sciences industry.
Foundational elements prior to using high-level data technologies such as Machine Learning and Artificial Intelligence.
DARSHAN SHAH
Senior Vice President and Chief Data Officer
Book of Data and Organizations: A census of health and health-related data, capabilities and talent in Indiana
BioCrossroads report underscores importance of strong tech transfer programs at Indiana’s research universities
INDIANAPOLIS, (Nov. 19, 2020) — BioCrossroads today released a new […]
Life Sciences Companies in Indiana by Employment
Indiana Life Sciences Capital: A Summary of 2019 Investments
An impressive $9.1 billion in capital was accessed by Indiana life sciences companies in 2019. The report details information on the types of funding, the companies who received capital, how much was funded, and the funders.
AXIS
AXIS is a new mentoring program focused on developing Indiana’s life sciences entrepreneurial talent.
INVEST IN
BioCrossroads has established itself as an important source of venture capital for Indiana’s life sciences industry through the formation of early-stage life sciences focused, return-driven investment funds.
